BDKRB1 and renal fibrosis: B1R blockade or ablation was also documented to be effective in ameliorating renal fibrosis in experimental obstructive nephropathy [7], reducing the renal inflammatory response in cisplatin or LPS-induced acute renal injury and ischemic-reperfusion injury in murine models [6, 23, 24].